Biologics Spine Cerapedics Announces First U.S. Patient Treated with PearlMatrix™ P-15 Peptide Enhanced Bone Graft following FDA approval byTim AllenJuly 8, 2025
Biologics Spine BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease byTim AllenJune 13, 2025
Biologics Spine Sports Medicine Dr. Ron Chatterjee of Joseph Spine Institute Appointed to the NFL-NFLPA Joint Pain Management Committee byTim AllenJune 12, 2025
Biologics Recon Spine Top Stories SINTX Technologies Announces Strategic Vision Focused on Expansion Across Key Sectors byJosh SandbergJune 12, 2025
Biologics Extremities Spine Sanuwave Health Appoints Industry Veteran Dustin Libby as Executive Vice President of Commercial Operations byTim AllenJune 3, 2025
Biologics Spine Sanuwave Health Appoints Greg Bazar to Board of Directors byJosh SandbergMay 28, 2025
Biologics Financial Top Stories Total Ancillary Joins Forces with WoundGenex byJosh SandbergMay 23, 2025
Biologics Sports Medicine APEX Biologix Enters Exclusive U.S. Distribution Agreement with Bioventus LLC for XCELL PRP® System byTim AllenMay 21, 2025
Biologics Top Stories Summit Products Group Launches to Transform Surgical and Regenerative Wound Care byTim AllenMay 15, 2025